» Articles » PMID: 38286985

Necroptosis Does Not Drive Disease Pathogenesis in a Mouse Infective Model of SARS-CoV-2 in Vivo

Abstract

Necroptosis, a type of lytic cell death executed by the pseudokinase Mixed Lineage Kinase Domain-Like (MLKL) has been implicated in the detrimental inflammation caused by SARS-CoV-2 infection. We minimally and extensively passaged a single clinical SARS-CoV-2 isolate to create models of mild and severe disease in mice allowing us to dissect the role of necroptosis in SARS-CoV-2 disease pathogenesis. We infected wild-type and MLKL-deficient mice and found no significant differences in viral loads or lung pathology. In our model of severe COVID-19, MLKL-deficiency did not alter the host response, ameliorate weight loss, diminish systemic pro-inflammatory cytokines levels, or prevent lethality in aged animals. Our in vivo models indicate that necroptosis is dispensable in the pathogenesis of mild and severe COVID-19.

Citing Articles

A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation.

Cheng L, Rui Y, Wang Y, Chen S, Su J, Yu X J Biomed Sci. 2024; 31(1):70.

PMID: 39003473 PMC: 11245872. DOI: 10.1186/s12929-024-01062-1.


The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo.

Kelepouras K, Saggau J, Varanda A, Zrilic M, Kiefer C, Rakhsh-Khorshid H Cell Death Differ. 2024; 31(7):897-909.

PMID: 38783091 PMC: 11239901. DOI: 10.1038/s41418-024-01313-6.


Blocking cell death limits lung damage and inflammation from influenza.

Gupta N, Silke J Nature. 2024; 628(8009):726-727.

PMID: 38600194 DOI: 10.1038/d41586-024-00910-2.


The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication.

Baker P, Bohrer A, Castro E, Amaral E, Snow-Smith M, Torres-Juarez F bioRxiv. 2024; .

PMID: 38585846 PMC: 10996686. DOI: 10.1101/2024.03.27.586885.

References
1.
Pasparakis M, Vandenabeele P . Necroptosis and its role in inflammation. Nature. 2015; 517(7534):311-20. DOI: 10.1038/nature14191. View

2.
M Bader S, Cooney J, Sheerin D, Taiaroa G, Harty L, Davidson K . SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates. Proc Natl Acad Sci U S A. 2023; 120(32):e2301689120. PMC: 10410703. DOI: 10.1073/pnas.2301689120. View

3.
Apetito Akamatsu M, de Castro J, Takano C, Ho P . Off balance: Interferons in COVID-19 lung infections. EBioMedicine. 2021; 73:103642. PMC: 8524139. DOI: 10.1016/j.ebiom.2021.103642. View

4.
Israelow B, Song E, Mao T, Lu P, Meir A, Liu F . Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J Exp Med. 2020; 217(12). PMC: 7401025. DOI: 10.1084/jem.20201241. View

5.
Muller T, Dewitz C, Schmitz J, Schroder A, Brasen J, Stockwell B . Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell Mol Life Sci. 2017; 74(19):3631-3645. PMC: 5589788. DOI: 10.1007/s00018-017-2547-4. View